How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona Meeting.

Sehouli J, Boer J, Brand AH, Oza AM, O'Donnell J, Bennett K, Glaspool R, Lee CK, Ethier JL, Harter P, Seebacher-Shariat V, Chang TC, Cohen PA, van Gorp T, Chavez-Blanco A, Welch S, Hranovska H, O'Toole S, Lok CAR, Madariaga A, Rauh-Hain JA, Perez Fidalgo A, Tan D, Michels J, Pothuri B, Fujiwara N, Rosengarten O, Nishio H, Kim SI, Mukopadhyay A, Piovano E, Cecere SC, Kohn EC, Mukherjee U, Nasser S, Lindemann K, Croke J, Chen X, Geissler F, Bookman MA

Open source

DOI
10.1136/ijgc-2024-005982
Published
2024 Nov 4
Container
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/ijgc-2024-005982,
  title = {How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona Meeting.},
  author = {Sehouli J and Boer J and Brand AH and Oza AM and O'Donnell J and Bennett K and Glaspool R and Lee CK and Ethier JL and Harter P and Seebacher-Shariat V and Chang TC and Cohen PA and van Gorp T and Chavez-Blanco A and Welch S and Hranovska H and O'Toole S and Lok CAR and Madariaga A and Rauh-Hain JA and Perez Fidalgo A and Tan D and Michels J and Pothuri B and Fujiwara N and Rosengarten O and Nishio H and Kim SI and Mukopadhyay A and Piovano E and Cecere SC and Kohn EC and Mukherjee U and Nasser S and Lindemann K and Croke J and Chen X and Geissler F and Bookman MA},
  year = {2024},
  journal = {International journal of gynecological cancer : official journal of the International Gynecological Cancer Society},
  doi = {10.1136/ijgc-2024-005982},
  url = {https://doi.org/10.1136/ijgc-2024-005982}
}

RIS

TY  - JOUR
TI  - How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona Meeting.
AU  - Sehouli J
AU  - Boer J
AU  - Brand AH
AU  - Oza AM
AU  - O'Donnell J
AU  - Bennett K
AU  - Glaspool R
AU  - Lee CK
AU  - Ethier JL
AU  - Harter P
AU  - Seebacher-Shariat V
AU  - Chang TC
AU  - Cohen PA
AU  - van Gorp T
AU  - Chavez-Blanco A
AU  - Welch S
AU  - Hranovska H
AU  - O'Toole S
AU  - Lok CAR
AU  - Madariaga A
AU  - Rauh-Hain JA
AU  - Perez Fidalgo A
AU  - Tan D
AU  - Michels J
AU  - Pothuri B
AU  - Fujiwara N
AU  - Rosengarten O
AU  - Nishio H
AU  - Kim SI
AU  - Mukopadhyay A
AU  - Piovano E
AU  - Cecere SC
AU  - Kohn EC
AU  - Mukherjee U
AU  - Nasser S
AU  - Lindemann K
AU  - Croke J
AU  - Chen X
AU  - Geissler F
AU  - Bookman MA
PY  - 2024
JO  - International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
DO  - 10.1136/ijgc-2024-005982
UR  - https://doi.org/10.1136/ijgc-2024-005982
ER  - 

APA

J, S., J, B., AH, B., AM, O., J, O., K, B., R, G., CK, L., JL, E., P, H., V, S., TC, C., PA, C., T, V. G., A, C., S, W., H, H., S, O., CAR, L., A, M., JA, R., A, P. F., D, T., J, M., B, P., N, F., O, R., H, N., SI, K., A, M., E, P., SC, C., EC, K., U, M., S, N., K, L., J, C., X, C., F, G., & MA, B. (2024). How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona Meeting.. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. https://doi.org/10.1136/ijgc-2024-005982

Source records